Ronald Shebuski, Ph.D.
Chief Scientific Officer
Dr. Shebuski has served as Chief Scientific Officer of Gene Biotherapeutics since May 2020. From 2016 to 2020 he served as the Vice President of Research and Development for InspiRx, Inc. and previously established Cardiovascular Research Consulting, LLC (1998 -2016), an advisory firm serving small, mid and large pharma companies. From 1990 to 1998 he served as the Director of Cardiovascular Therapeutics at Pharmacia & Upjohn (1990-1998). Dr. Shebuski received his B.S. Degree in Microbiology from the University of Wisconsin at Madison and Ph.D. Degree in Pharmacology from the University of Minnesota Medical School.
